Literature DB >> 28260724

Role of NLRP3 Inflammasomes in Atherosclerosis.

Tadayoshi Karasawa1, Masafumi Takahashi1.   

Abstract

Inflammation with macrophage infiltration is a key feature of atherosclerosis. Although the mechanisms had been unclear, emerging evidence unveiled that NLRP3 inflammasomes, which regulate caspase-1 activation and subsequent processing of pro-IL-1β, trigger vascular wall inflammatory responses and lead to progression of atherosclerosis. NLRP3 inflammasomes are activated by various danger signals, such as cholesterol crystals, calcium phosphate crystals, and oxidized low-density lipoprotein in macrophages, to initiate inflammatory responses in the atherosclerotic lesion. Recent studies have further clarified the regulatory mechanisms and the potential therapeutic agents that target NLRP3 inflammasomes. In this study, we reviewed the present state of knowledge on the role of NLRP3 inflammasomes in the pathogenesis of atherosclerosis and discussed the therapeutic approaches that target NLRP3 inflammasomes.

Entities:  

Keywords:  Cholesterol; Cytokines; Inflammation; Interleukin-1; Leukocytes

Mesh:

Substances:

Year:  2017        PMID: 28260724      PMCID: PMC5429158          DOI: 10.5551/jat.RV17001

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  52 in total

Review 1.  Mechanisms and functions of inflammasomes.

Authors:  Mohamed Lamkanfi; Vishva M Dixit
Journal:  Cell       Date:  2014-05-22       Impact factor: 41.582

2.  Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury.

Authors:  Masanori Kawaguchi; Masafumi Takahashi; Takeki Hata; Yuichiro Kashima; Fumitake Usui; Hajime Morimoto; Atsushi Izawa; Yasuko Takahashi; Junya Masumoto; Jun Koyama; Minoru Hongo; Tetsuo Noda; Jun Nakayama; Junji Sagara; Shun'ichiro Taniguchi; Uichi Ikeda
Journal:  Circulation       Date:  2011-01-31       Impact factor: 29.690

3.  Autophagy links inflammasomes to atherosclerotic progression.

Authors:  Babak Razani; Chu Feng; Trey Coleman; Roy Emanuel; Haitao Wen; Seungmin Hwang; Jenny P Ting; Herbert W Virgin; Michael B Kastan; Clay F Semenkovich
Journal:  Cell Metab       Date:  2012-03-20       Impact factor: 27.287

4.  Caspase-1 deficiency decreases atherosclerosis in apolipoprotein E-null mice.

Authors:  Jessica Gage; Mirela Hasu; Mohamed Thabet; Stewart C Whitman
Journal:  Can J Cardiol       Date:  2012-01-21       Impact factor: 5.223

5.  A pre-aspartate-specific protease from human leukocytes that cleaves pro-interleukin-1 beta.

Authors:  R A Black; S R Kronheim; J E Merriam; C J March; T P Hopp
Journal:  J Biol Chem       Date:  1989-04-05       Impact factor: 5.157

6.  A role for mitochondria in NLRP3 inflammasome activation.

Authors:  Rongbin Zhou; Amir S Yazdi; Philippe Menu; Jürg Tschopp
Journal:  Nature       Date:  2010-12-01       Impact factor: 49.962

7.  Associations between Inflammatory Markers and Subclinical Atherosclerosis in Middle-aged White, Japanese-American and Japanese Men: The ERA-JUMP Study.

Authors:  Shin-Ya Nagasawa; Takayoshi Ohkubo; Kamal Masaki; Emma Barinas-Mitchell; Katsuyuki Miura; ToddB Seto; Aiman El-Saed; Takashi Kadowaki; Bradley J Willcox; Daniel Edmundowicz; Aya Kadota; Rhobert W Evans; Sayaka Kadowaki; Akira Fujiyoshi; Takashi Hisamatsu; Marianne H Bertolet; Tomonori Okamura; Yasuyuki Nakamura; Lewis H Kuller; Hirotsugu Ueshima; Akira Sekikawa
Journal:  J Atheroscler Thromb       Date:  2014-11-29       Impact factor: 4.928

8.  Inflammasome activation by mitochondrial oxidative stress in macrophages leads to the development of angiotensin II-induced aortic aneurysm.

Authors:  Fumitake Usui; Koumei Shirasuna; Hiroaki Kimura; Kazuki Tatsumi; Akira Kawashima; Tadayoshi Karasawa; Koichi Yoshimura; Hiroki Aoki; Hiroko Tsutsui; Tetsuo Noda; Junji Sagara; Shun'ichiro Taniguchi; Masafumi Takahashi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-11-06       Impact factor: 8.311

9.  Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme.

Authors:  Y Gu; K Kuida; H Tsutsui; G Ku; K Hsiao; M A Fleming; N Hayashi; K Higashino; H Okamura; K Nakanishi; M Kurimoto; T Tanimoto; R A Flavell; V Sato; M W Harding; D J Livingston; M S Su
Journal:  Science       Date:  1997-01-10       Impact factor: 47.728

10.  Induction of lysosomal biogenesis in atherosclerotic macrophages can rescue lipid-induced lysosomal dysfunction and downstream sequelae.

Authors:  Roy Emanuel; Ismail Sergin; Somashubhra Bhattacharya; Jaleisa Turner; Slava Epelman; Carmine Settembre; Abhinav Diwan; Andrea Ballabio; Babak Razani
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-24       Impact factor: 8.311

View more
  70 in total

Review 1.  Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.

Authors:  Mohan Satish; Devendra K Agrawal
Journal:  Transl Res       Date:  2019-08-12       Impact factor: 7.012

2.  TLR4 regulates vascular smooth muscle cell proliferation in hypertension via modulation of the NLRP3 inflammasome.

Authors:  Hui-Meng Qi; Qin Cao; Qiang Liu
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

3.  Increased serum uric acid levels are associated with digital ulcers in patients with systemic sclerosis.

Authors:  Eunsung Kim; Han-Na Lee; Yun-Kyung Kim; Geun-Tae Kim; Min Wook So; Eunyoung Ahn; Dong Hyun Sohn; Seung-Geun Lee
Journal:  Rheumatol Int       Date:  2019-01-17       Impact factor: 2.631

Review 4.  The Interplay of Lipids, Lipoproteins, and Immunity in Atherosclerosis.

Authors:  Angela Pirillo; Fabrizia Bonacina; Giuseppe Danilo Norata; Alberico Luigi Catapano
Journal:  Curr Atheroscler Rep       Date:  2018-02-14       Impact factor: 5.113

5.  Irisin Alleviates Advanced Glycation End Products-Induced Inflammation and Endothelial Dysfunction via Inhibiting ROS-NLRP3 Inflammasome Signaling.

Authors:  Xian Deng; Wei Huang; Juan Peng; Ting-Ting Zhu; Xiao-Lei Sun; Xiang-Yu Zhou; Hui Yang; Jian-Feng Xiong; Hu-Qiang He; You-Hua Xu; Yan-Zheng He
Journal:  Inflammation       Date:  2018-02       Impact factor: 4.092

6.  TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia.

Authors:  Sebastian Vogel; Pranav Murthy; Xiangdong Cui; Michael T Lotze; Herbert J Zeh; Ulka Sachdev
Journal:  Biochem Biophys Res Commun       Date:  2018-12-03       Impact factor: 3.575

Review 7.  The NLRP3 Inflammasome and Its Role in Sepsis Development.

Authors:  Lucinéia Gainski Danielski; Amanda Della Giustina; Sandra Bonfante; Tatiana Barichello; Fabricia Petronilho
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 8.  Potential role of IL-37 in atherosclerosis.

Authors:  Sara McCurdy; Chloe A Liu; Jonathan Yap; William A Boisvert
Journal:  Cytokine       Date:  2017-10-05       Impact factor: 3.861

9.  P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant Model.

Authors:  Alexandra Y Soare; Natasha D Durham; Ramya Gopal; Benjamin Tweel; Kevin W Hoffman; Julia A Brown; Megan O'Brien; Nina Bhardwaj; Jean K Lim; Benjamin K Chen; Talia H Swartz
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

Review 10.  NLRP3 Inflammasome in Inflammation and Metabolism: Identifying Novel Roles in Postburn Adipose Dysfunction.

Authors:  Roohi Vinaik; Dalia Barayan; Marc G Jeschke
Journal:  Endocrinology       Date:  2020-09-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.